Introduction
A diagnosis of lung cancer often brings a flood of questions, concerns, and uncertainty. One of the most common fears patients have is whether they will lose a large portion of their lung—or even an entire lung—to cure the disease. This is when Lung Cancer treatment with Segmentectomy comes into the picture for early lesions.
Fortunately, modern thoracic surgery has evolved significantly over the past decade. Today, many patients diagnosed with early-stage lung cancer may be candidates for a lung-preserving operation known as segmentectomy. Rather than removing an entire lobe of the lung, segmentectomy removes only the affected anatomical segment while preserving as much healthy lung tissue as possible.
This shift toward precision surgery has been driven by advances in CT imaging, early cancer detection, minimally invasive surgical techniques, and landmark international research studies. For carefully selected patients, segmentectomy offers an opportunity to achieve excellent cancer control while maintaining better long-term lung function and quality of life.
At specialized thoracic surgery centers, segmentectomy is increasingly becoming an important part of the treatment strategy for selected lung cancers. Understanding when segmentectomy is appropriate—and when a more extensive operation such as lobectomy may still be necessary—is essential for every patient diagnosed with early-stage lung cancer.
What Is Segmentectomy?
The lungs are divided into lobes, and each lobe is further subdivided into smaller anatomical units called segments. Each segment has its own airway, blood vessels, and lymphatic drainage, allowing it to be removed independently while preserving the surrounding lung tissue.
A segmentectomy is a surgical procedure in which one or more of these anatomical lung segments are removed while leaving the remainder of the lobe intact.
Unlike a wedge resection, which removes a tumor with a small rim of surrounding lung tissue, segmentectomy follows precise anatomical boundaries and includes formal lymph node assessment. This makes it a much more oncologically sound operation for lung cancer treatment.
The objective is straightforward:
Remove all cancerous tissue while preserving the maximum amount of healthy lung.
Think of it as repairing a damaged section of a building rather than demolishing the entire structure. The cancer is removed, but the healthy portions of the lung continue functioning normally.
Today, most segmentectomies are performed using minimally invasive approaches such as:
- Video-Assisted Thoracoscopic Surgery (VATS)
- Robotic Thoracic Surgery
These techniques allow complex lung resections to be performed through small incisions with less pain and faster recovery compared with traditional open surgery.
Why Is Lung Cancer Treatment with Segmentectomy Becoming More Common?
Only a decade ago, lobectomy was considered the standard treatment for nearly every patient with early-stage non-small cell lung cancer.
Today, the landscape is changing.
The widespread availability of high-resolution CT scans has resulted in the detection of much smaller lung cancers than ever before. Many tumors are identified before symptoms develop and often measure less than 2 centimeters.
As surgeons gained experience and researchers accumulated data, an important question emerged:
Does every small lung cancer require removal of an entire lobe?
Several landmark international studies have helped answer this question.
The most influential among these is the JCOG0802/WJOG4607L Trial, a large multicenter Japanese study that compared segmentectomy with lobectomy in patients with small peripheral non-small cell lung cancers. The study demonstrated excellent long-term survival following segmentectomy and showed that carefully selected patients could achieve outcomes comparable to, and in some aspects better than, lobectomy while preserving more healthy lung tissue.
Reference: Saji H et al. Segmentectomy versus Lobectomy in Small-Sized Peripheral Non-Small Cell Lung Cancer (JCOG0802/WJOG4607L). Journal of Thoracic and Cardiovascular Surgery. 2022.
These findings have significantly influenced modern lung cancer treatment guidelines worldwide and accelerated the adoption of segmentectomy as an evidence-based surgical option.
Which Lung Cancer Patients Are Suitable for Segmentectomy Treatment?
Not every patient with lung cancer is a candidate for segmentectomy.
Careful patient selection remains the key to success.
The ideal candidate typically has:
- A tumor measuring 2 cm or less
- A peripheral lung cancer
- No evidence of lymph node involvement
- No distant metastases
- Adequate surgical margins achievable
Many of these cancers are detected incidentally during CT scans performed for unrelated reasons. Others are identified through lung cancer screening programs in high-risk individuals.
Tumor location is equally important. Lesions situated in the outer regions of the lung are often more suitable for segmentectomy than tumors located close to major airways or blood vessels.
Current international guidelines increasingly support anatomical segmentectomy for carefully selected patients.
The National Comprehensive Cancer Network (NCCN) and the American College of Chest Physicians (CHEST) recognize segmentectomy as an appropriate treatment option for selected peripheral tumors measuring 2 cm or less, provided adequate surgical margins and systematic lymph node evaluation can be achieved.
Reference: NCCN Clinical Practice Guidelines in Oncology – Non-Small Cell Lung Cancer.
Reference: CHEST Guideline and Expert Panel Report on Surgical Management of Early-Stage Non-Small Cell Lung Cancer.
The final decision should always be made after a comprehensive evaluation by an experienced thoracic surgeon.
Can Segmentectomy Be Used for All Types of Lung Cancer?
The simple answer is no.
Segmentectomy is most effective in carefully selected early-stage cancers.
Early-Stage Non-Small Cell Lung Cancer (NSCLC)
The most common indication for segmentectomy is early-stage NSCLC, including:
- Adenocarcinoma
- Squamous Cell Carcinoma
- Selected large cell carcinomas
Adenocarcinoma is currently the most common form of lung cancer worldwide and is increasingly diagnosed at an early stage due to widespread CT imaging.
Many of these patients are excellent candidates for segmentectomy.
Ground Glass Nodules and Early Adenocarcinoma
Ground glass opacities are becoming increasingly common findings on CT scans.
Some represent pre-invasive lesions, while others are very early adenocarcinomas.
Because these lesions often grow slowly and have lower rates of lymph node spread, segmentectomy may provide excellent oncological outcomes while preserving lung tissue.
Selected Pulmonary Metastases
In carefully chosen circumstances, segmentectomy may also be considered for metastatic tumors that have spread to the lungs from other organs.
The decision depends on:
- Number of lesions
- Tumor biology
- Disease-free interval
- Lung function
- Overall cancer status
What Do International Guidelines Say About Segmentectomy?
Modern thoracic oncology guidelines have evolved significantly over the past decade.
Historically, lobectomy was considered mandatory for virtually all operable lung cancers.
Today, evidence-based guidelines recognize that selected patients may achieve excellent outcomes with less extensive surgery.
Current recommendations generally support segmentectomy when:
- Tumor size is 2 cm or smaller
- The lesion is located in the peripheral third of the lung
- Adequate margins can be achieved
- Systematic lymph node assessment is performed
- Surgery is performed by an experienced thoracic surgeon
These recommendations are supported by:
- NCCN Guidelines
- CHEST Guidelines
- European Society of Thoracic Surgeons (ESTS) Guidelines
The message is clear:
“Segmentectomy is no longer considered a compromise operation. It is now an accepted oncological procedure for appropriately selected patients.“
When Is Lobectomy Still Preferred?
Despite the increasing role of segmentectomy, lobectomy remains the preferred treatment in many situations.
Lobectomy is often recommended when:
- Tumors exceed 2 cm
- Lymph nodes appear involved
- The lesion is centrally located
- Multiple tumors exist within the same lobe
- Adequate margins cannot be achieved with segmentectomy
Cancer surgery is not simply about removing the visible tumor.
The operation must also remove enough surrounding tissue to minimize recurrence risk.
If this cannot be achieved safely with a segmentectomy, a lobectomy may provide superior cancer control.
The goal is not to perform the smallest operation.
The goal is to perform the right operation.
Benefits of Segmentectomy for Lung Cancer Patients
One of the most compelling advantages of segmentectomy is preservation of lung function.
By removing less healthy lung tissue, patients often maintain greater breathing capacity after surgery.
This can be particularly valuable in:
- Smokers
- Former smokers
- COPD patients
- Elderly individuals
- Patients with emphysema
- Patients who may require future lung surgery
Better Preservation of Breathing Capacity
Preserving lung tissue means preserving respiratory reserve.
Many patients notice less impact on exercise tolerance and daily activities after surgery.
Improved Quality of Life
Maintaining better lung function often translates into greater independence and improved long-term quality of life.
Future Surgical Options
Should another lung lesion develop in the future, preserved lung tissue may provide additional treatment options.
Excellent Cancer Outcomes
The landmark CALGB 140503 Trial, published in the New England Journal of Medicine, demonstrated that sublobar resection, including anatomical segmentectomy, could achieve outcomes comparable to lobectomy in selected patients with small peripheral lung cancers.
Reference: Altorki NK et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small Cell Lung Cancer (CALGB 140503). New England Journal of Medicine. 2023.
How Is Segmentectomy Performed?
Successful segmentectomy begins long before the patient enters the operating room.
Detailed preoperative planning is critical.
Investigations typically include:
- CT Scan
- PET-CT Scan
- Pulmonary Function Tests
- Cardiac Evaluation
- Bronchoscopy when required
Many thoracic surgeons now use advanced three-dimensional imaging reconstruction to map blood vessels and bronchi before surgery.
During the operation:
- The segmental artery is identified and divided.
- The segmental vein is preserved or divided as appropriate.
- The segmental bronchus is isolated.
- The affected segment is removed.
- Systematic lymph node assessment is performed.
- The specimen is sent for pathological evaluation.
Most modern segmentectomies are performed using VATS or robotic surgery, allowing patients to benefit from smaller incisions and faster recovery.
Recovery After Segmentectomy
Recovery following minimally invasive segmentectomy is often quicker than many patients expect.
Most patients remain in the hospital for approximately three to five days.
During recovery, patients are encouraged to:
- Walk early
- Perform breathing exercises
- Use incentive spirometry
- Gradually increase activity levels
Temporary symptoms may include:
- Mild chest discomfort
- Fatigue
- Shortness of breath with exertion
- Shoulder discomfort
These symptoms generally improve steadily over several weeks.
Most patients return to normal daily activities within two to four weeks, although recovery varies depending on age, lung function, and overall health.
Does Segmentectomy Cure Lung Cancer?
For carefully selected patients with early-stage lung cancer, segmentectomy can be a curative treatment.
However, surgery represents only one component of successful cancer management.
Long-term outcomes depend on:
- Accurate staging
- Complete tumor removal
- Adequate surgical margins
- Proper lymph node assessment
- Regular surveillance
Patients typically undergo periodic CT scans after surgery to monitor for recurrence.
The earlier lung cancer is detected, the greater the opportunity for cure.
This is one reason why lung cancer screening programs are becoming increasingly important worldwide.
Detecting cancer before symptoms appear often creates the possibility of lung-preserving procedures such as segmentectomy.
Advanced Segmentectomy Surgery in Delhi
Segmentectomy is among the most technically demanding procedures in thoracic surgery.
Successful outcomes depend not only on selecting the right patient but also on meticulous surgical execution.
Dr. Kamran Ali specializes in minimally invasive thoracic surgery, including VATS and robotic anatomical segmentectomy. His experience includes complex segmental resections and the first reported VATS Left S10 Segmentectomy from India. Through advanced imaging, precise anatomical dissection, and comprehensive lymph node evaluation, the goal is always to achieve optimal cancer control while preserving maximum healthy lung tissue.
Patients diagnosed with a lung nodule or early-stage lung cancer should seek evaluation from a dedicated thoracic surgeon who can discuss all available treatment options and develop an individualized treatment strategy.
Conclusion
Segmentectomy has transformed the treatment landscape for selected patients with early-stage lung cancer. By removing only the diseased segment of the lung, this procedure offers the possibility of curing cancer while preserving valuable lung function and quality of life.
Modern clinical trials and international guidelines now support segmentectomy as an evidence-based treatment option for carefully selected small peripheral lung cancers. At the same time, lobectomy remains the preferred operation in many circumstances, highlighting the importance of individualized treatment planning.
For patients diagnosed with a lung nodule or early-stage lung cancer, expert evaluation by an experienced thoracic surgeon is essential. The best outcomes are achieved when surgery is tailored not only to the cancer but also to the patient.
Scientific References
- Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus Lobectomy in Small-Sized Peripheral Non-Small Cell Lung Cancer (JCOG0802/WJOG4607L). Journal of Thoracic and Cardiovascular Surgery. 2022.
- Altorki NK, Wang X, Wigle D, et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small Cell Lung Cancer (CALGB 140503). New England Journal of Medicine. 2023.
- National Comprehensive Cancer Network (NCCN) Guidelines – Non-Small Cell Lung Cancer.
- American College of Chest Physicians (CHEST) Guideline and Expert Panel Report – Surgical Management of Early-Stage NSCLC.
- European Society of Thoracic Surgeons (ESTS) Guidelines for Lung Cancer Surgery.
Related Articles
- Segmentectomy Surgery in India
- Segmentectomy vs Lobectomy
- VATS Segmentectomy Surgery
- Recovery After Segmentectomy
- Cost of Segmentectomy Surgery in India
